Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Diaceutics invests in patient data to improve outcomes
  2. British universities must improve clinical trial reporting, says House of Commons
  3. Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
  4. Industry Viewpoints: Leveraging eSource in Data Management
  5. The Fundamentals Behind Effective Data Management

Company A-Z

Latest Content

August’s top news stories

Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN) patients; and MyoKardia has commenced dosing of patients in a Phase I trial of small molecule MYK-224 for the treatment of hypertrophic cardiomyopathy (HCM). Clinicaltrialsarena.com wraps up the key headlines from August 2019.

Latest News

Close
Close
Close

Go Top